Noticias

Compartir en Facebook Compartir en Twiter Compartir en Menéame Compartir en Linkedin Suscribirse a nuestra RSS

El CBD dispone de péptidos protectores que reducen el daño pulmonar del COVID-19

t-care/100476/" title="" target="_blank">A new study by researchers from the Medical College of Georgia has shown that CBD improves oxygen levels, reduces inflammation and lung damage caused by COVID. When a patient is infected, a peptide called appelin is drastically reduced, this peptide has anti-inflammatory effects and its deficiency is one of those responsible for the acute respiratory distress syndrome, ARDS. CBD has the ability to normalize apelin levels thereby reducing inflammation and the effects of ARDS.

This is important for several reasons, in our body normal blood levels of apelin indicate optimal blood pressure. When it makes an appearance, the levels of apelin practically disappear, which causes blood pressure and lung inflammation to grow uncontrollably.

When CBD was administered, these levels increased up to 20 times, immediately reducing the effects of RSDA and improving the general picture of the patient.

In addition, the levels of this peptide will serve as an early biomarker of this and other diseases that cause RSDA.

Another avenue of research has to do with the ACE2 receptor, this receptor found on the membrane of our cells. Apelin and ACE2 work together to control blood pressure. The problem is that COVID uses ACE2 receptors as a gateway and in doing so increases the levels of the constrictor vessel angiotensin II, worsening the patient"s general picture.

From what they have been able to see, CBD interferes with the COVID entry process through ACE2 receptors and by also increasing the levels of apelin, it favors the recovery of the damage caused by the virus and interferes with the proliferation in our body.

We will continue to closely monitor these investigations because of how promising they look and the benefit they bring to COVID patients.